Doctors at Tata Memorial Centre have made a groundbreaking discovery related to cancer metastasis, revealing that dying cancer cells release ‘chromosome fragments’ that can fuse with healthy cells, potentially causing new tumors. In response to this finding, the researchers have developed a nutraceutical therapy to mitigate the risk of metastasis. The therapy, a combination of copper and plant extracts, could offer significant advancements in cancer treatment.
Background on the Research and Discovery:
The decade-long research conducted by Tata Memorial Centre has uncovered a mechanism for cancer metastasis that involves the release of ‘chromosome fragments’ or chromatin from dying cancer cells. These chromatin fragments can fuse with healthy cells, leading to the formation of new tumors. The study emphasizes the potential risks associated with current cancer treatment practices, particularly chemotherapy and radiotherapy, which can inadvertently contribute to metastasis.
In response to the identified risk, the researchers have developed a nutraceutical therapy using copper and plant extracts (grapes or berries) to neutralize the released chromatin fragments. The therapy aims to reduce the risk of metastasis and could be prescribed as supportive treatment alongside traditional chemotherapy. Tying up with a nutraceutical manufacturer, Tata Memorial Centre plans to make this therapy available by June.
The breakthrough discovery challenges the conventional understanding of cancer metastasis, emphasizing the need to consider chromatin fragments as potential triggers for metastatic cancer spread. The nutraceutical therapy, known as R-Cu, has shown promising results in initial trials with patients suffering from various cancers. The potential reduction in the toxicity of chemotherapy and its supportive role in treatment could reshape cancer treatment policies.
Conclusion and Impact:
Tata Memorial Centre’s research and the development of a nutraceutical therapy mark a significant milestone in understanding and addressing cancer metastasis. The findings have far-reaching implications for cancer treatment, encouraging a reevaluation of existing protocols and the inclusion of agents that target chromatin fragments. As nutraceutical therapy progresses toward wider adoption, it holds the potential to enhance its effectiveness and reduce the risks associated with cancer treatment, offering new hope to patients worldwide.
